Regencell Bioscience Holdings Limited (RGC) vs Veracyte, Inc. (VCYT)
A side-by-side comparison of Regencell Bioscience Holdings Limited and Veracyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RGC
Regencell Bioscience Holdings Limited
$7.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VCYT
Veracyte, Inc.
$44.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — RGC vs VCYT
growth of $100 · dividends reinvested · last 5yRGC +2520.2% (+92.2%/yr)VCYT +25.0% (+4.6%/yr)RGC compounded faster over this window
Log scale — wide-divergence pair
RGC VCYT
RGC vs VCYT: by the numbers
- •RGC is the larger company ($3.64B vs $3.56B market cap).
- •VCYT is profitable (20.37% net margin) while RGC runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | RGC | VCYT |
|---|---|---|
| P/E ratio | N/A | 31.89 |
| Forward P/E | N/A | 23.33 |
| P/S ratio | N/A | 6.34 |
| P/B ratio | 2986.54 | 2.57 |
| EV / EBITDA | N/A | 28.34 |
| FCF yield | N/A | 4.64% |
Profitability
| Metric | RGC | VCYT |
|---|---|---|
| Gross margin | 0.00% | 72.09% |
| Operating margin | 0.00% | 17.03% |
| Net margin | 0.00% | 20.37% |
| ROE | -73.75% | 8.25% |
| ROIC | -69.75% | 6.72% |
Growth (annualized)
| Metric | RGC | VCYT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 28.98% |
| Total return CAGR (5Y) | 67.94% | 1.45% |
Frequently asked
- Is RGC or VCYT more profitable?
- VCYT runs the higher net margin — RGC at 0.00% versus VCYT at 20.37%.
- How have RGC and VCYT total returns compared?
- Over the past 5 years, RGC delivered 67.94% and VCYT delivered 1.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Veracyte P/E ratioRegencell Bioscience ROEVeracyte ROERegencell Bioscience operating marginVeracyte operating marginRegencell Bioscience revenue growthVeracyte revenue growthRegencell Bioscience free cash flowVeracyte free cash flow
Regencell Bioscience & Veracyte appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.